Cargando…
Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses
The limited efficacy of existing antiviral therapies for influenza – coupled with widespread baseline antiviral resistance – highlights the urgent need for more effective therapy. We describe a triple combination antiviral drug (TCAD) regimen composed of amantadine, oseltamivir, and ribavirin that i...
Autores principales: | Nguyen, Jack T., Smee, Donald F., Barnard, Dale L., Julander, Justin G., Gross, Matthew, de Jong, Menno D., Went, Gregory T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264642/ https://www.ncbi.nlm.nih.gov/pubmed/22292088 http://dx.doi.org/10.1371/journal.pone.0031006 |
Ejemplares similares
-
Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro
por: Nguyen, Jack T., et al.
Publicado: (2010) -
Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus
por: Hoopes, Justin D., et al.
Publicado: (2011) -
Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization
por: Zhang, Yingjie, et al.
Publicado: (2013) -
Oseltamivir- and Amantadine-Resistant Influenza Virus A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2010) -
Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2009)